<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01160692</url>
  </required_header>
  <id_info>
    <org_study_id>11954</org_study_id>
    <nct_id>NCT01160692</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate The Effects Of a Multivitamin/Mineral With Ginko In Subjects With Age Associated Memory Impairment</brief_title>
  <official_title>A Randomized, Placebo-controlled, Parallel Group, Double Blind Study to Evaluate the Cognitive Effects and Tolerance of a Multi-Vitamin/Mineral Preparation Containing Gingko in Elderly Subjects With Age Associated Memory Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Study to evaluate the cognitive effects and tolerance of a Multi-Vitamin/Mineral
      Preperation containing Gingko in elderly subjects with age associated memory impairment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of the multi-vitamin/-mineral preparation containing gingko on major aspects of human cognitive function employing a computerized cognitive assessment system.</measure>
    <time_frame>From baseline up to 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effects of the multi-vitamin/-mineral preparation containing gingko on subjective memory using questionnaires.</measure>
    <time_frame>From baseline up to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of the daily oral intake of the multi-vitamin/-mineral preparation containing gingko.</measure>
    <time_frame>From baseline up to 14 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effects of the multi-vitamin/-mineral preparation containing gingko on mood using questionnaires.</measure>
    <time_frame>From baseline up to 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Age-Related Memory Disorders</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamin/Multimineral/Ginkgo (BAY 81-2775)</intervention_name>
    <description>Multivitamin/Multimineral/Ginkgo (BAY 81-2775), daily oral intake of film coated tablets for 3 months</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily oral intake of matching placebo tablets for 3 months</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is generally healthy (includes subjects presenting with mild chronic diseases
             where the disease and/or the pharmacological treatment does not result in psychomotor
             impairment or improvement).

          -  Subject is of either gender, and 60+ years of age, inclusive.

          -  Subject demonstrates Age Associated Memory Impairment after completion of the CDR test
             battery and comparison to normative data.

          -  Female subject who is post-menopausal.

          -  Subject is able to understand the study instructions and has given written informed
             consent prior to study participation.

          -  Subject admitted to this study is oriented to person, place and time and has the
             ability to communicate with the study staff.

          -  Subject is, in the opinion of the study staff, motivated to participate and complete
             the study as instructed.

          -  Subject is willing to be attend visits in a well-rested state.

        Exclusion Criteria:

          -  Subject has participated in an interventional study within the one month prior to
             screening.

          -  Intake within three months prior to screening, or intended intake during the study, of
             one of the following: Ginkgo biloba, St John's Wort, Ginseng, Gotu Kola (Indian
             Pennywort), or daily doses of vitamin E (-tocopherol) above 30 mg, folic acid above
             400 g, vitamins B-1 (thiamine), B-2 (riboflavin), B-6 (pyridoxine) above 2 mg, or
             other cognition enhancers.

          -  Subject has a history of a psychological illness or condition such as to interfere
             with the subject's ability to understand the requirements of the study.

          -  Subject has a history of Alzheimers disease, dementia, mental retardation, Morbus
             Parkinson, or any other mental disorders.

          -  Subject has not been diagnosed with AAMI after completion of the CDR test battery and
             comparison to normative data.

          -  Subject has a history of any bleeding/coagulation disorder (e.g., haemophilia, Protein
             C or S deficiency).

          -  Subject is taking/being treated with a concomitant medication which may affect/inhibit
             blood coagulation (e.g., warfarin, aspirin, heparin).

          -  Subject has history of relevant vascular disorders (e.g., carotid stenosis, stroke,
             PRIND, coronary artery disease, peripheral vascular disease, thrombosis).

          -  Subject has Body Mass Index (BMI) above 40 kg/m2 (severely obese).

          -  Subject smokes more than 15 cigarettes, or equivalent daily.

          -  Subject has moderate-to-severe hepatic impairment.

          -  Subject has history of alcohol or drug abuse.

          -  Subject has known allergies or intolerance to any ingredients in the study
             preparations.

          -  Subject is intending to undergo surgery during or immediately upon completion (within
             two weeks) of study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE1 8ST</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2009</study_first_submitted>
  <study_first_submitted_qc>July 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2010</study_first_posted>
  <last_update_submitted>July 30, 2010</last_update_submitted>
  <last_update_submitted_qc>July 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Therapeutic Area Head</name_title>
    <organization>Bayer Healthcare AG</organization>
  </responsible_party>
  <keyword>Memory</keyword>
  <keyword>Cognitive Function</keyword>
  <keyword>Elderly</keyword>
  <keyword>Gingko</keyword>
  <keyword>Age Associated Memory Impairment (AAMI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Memory Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

